Peter Welch actually said...

I don't see that as R&D.

All of us have a concern about a formulary. Is that going to restrict patient access?

Solving this drug-pricing crisis will require a multifaceted approach that addresses the misaligned incentives throughout the supply chain t...

There ought to be transparency--transparency on the rebates and, I think, transparency on how much is really spent on R&D.